129 related articles for article (PubMed ID: 17046775)
1. Development of recombinant protein-based influenza vaccine. Expression and affinity purification of H1N1 influenza virus neuraminidase.
Dalakouras T; Smith BJ; Platis D; Cox MM; Labrou NE
J Chromatogr A; 2006 Dec; 1136(1):48-56. PubMed ID: 17046775
[TBL] [Abstract][Full Text] [Related]
2. Lock-and-key motif as a concept for designing affinity adsorbents for protein purification.
Platis D; Sotriffer CA; Clonis Y; Labrou NE
J Chromatogr A; 2006 Sep; 1128(1-2):138-51. PubMed ID: 16860333
[TBL] [Abstract][Full Text] [Related]
3. Nucleotide-mimetic synthetic ligands for DNA-recognizing enzymes One-step purification of Pfu DNA polymerase.
Melissis S; Labrou NE; Clonis YD
J Chromatogr A; 2006 Jul; 1122(1-2):63-75. PubMed ID: 16712859
[TBL] [Abstract][Full Text] [Related]
4. One-step purification of Taq DNA polymerase using nucleotide-mimetic affinity chromatography.
Melissis S; Labrou NE; Clonis YD
Biotechnol J; 2007 Jan; 2(1):121-32. PubMed ID: 17183508
[TBL] [Abstract][Full Text] [Related]
5. [Expression of neuraminidase gene of influenza virus H1N1 in baculovirus-expression system].
Yao LH; Fu JQ; Chen AJ; Liu XY; Xu PW; Guo JQ; Zhang LC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Apr; 27(2):81-4. PubMed ID: 24044206
[TBL] [Abstract][Full Text] [Related]
6. Interaction of L-glutamate oxidase with triazine dyes: selection of ligands for affinity chromatography.
Katsos NE; Labrou NE; Clonis YD
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Aug; 807(2):277-85. PubMed ID: 15203041
[TBL] [Abstract][Full Text] [Related]
7. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection.
Sylte MJ; Hubby B; Suarez DL
Vaccine; 2007 May; 25(19):3763-72. PubMed ID: 17350145
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial de novo design and application of a biomimetic affinity ligand for the purification of human anti-HIV mAb 4E10 from transgenic tobacco.
Platis D; Maltezos A; Ma JK; Labrou NE
J Mol Recognit; 2009; 22(6):415-24. PubMed ID: 19431140
[TBL] [Abstract][Full Text] [Related]
9. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
10. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
11. Changing perspective on immunization against influenza.
Johansson BE; Brett IC
Vaccine; 2007 Apr; 25(16):3062-5. PubMed ID: 17276554
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis, cloning and determination of the primary structure of a full-size DNA copy of the neuraminidase gene from influenza virus type A subtype H1N1].
Beklemishev AB; Blinov VM; Vasilenko SK; Golovin SIa; Karginov VA
Bioorg Khim; 1985 May; 11(5):628-35. PubMed ID: 4038348
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and application of benzyl-sulfonate biomimetic affinity adsorbents for monoclonal antibody purification from transgenic corn.
Maltezos A; Platis D; Vlachakis D; Kossida S; Marinou M; Labrou NE
J Mol Recognit; 2014 Jan; 27(1):19-31. PubMed ID: 24375581
[TBL] [Abstract][Full Text] [Related]
14. Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.
Tanimoto T; Nakatsu R; Fuke I; Ishikawa T; Ishibashi M; Yamanishi K; Takahashi M; Tamura S
Vaccine; 2005 Aug; 23(37):4598-609. PubMed ID: 15964668
[TBL] [Abstract][Full Text] [Related]
15. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells.
Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA
J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028
[TBL] [Abstract][Full Text] [Related]
16. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.
Eshaghi A; Bolotin S; Burton L; Low DE; Mazzulli T; Drews SJ
J Clin Virol; 2009 Jun; 45(2):142-5. PubMed ID: 19451021
[TBL] [Abstract][Full Text] [Related]
17. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge.
Haynes JR; Dokken L; Wiley JA; Cawthon AG; Bigger J; Harmsen AG; Richardson C
Vaccine; 2009 Jan; 27(4):530-41. PubMed ID: 19026705
[TBL] [Abstract][Full Text] [Related]
18. Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
Abed Y; Nehmé B; Baz M; Boivin G
Antiviral Res; 2008 Feb; 77(2):163-6. PubMed ID: 17919743
[TBL] [Abstract][Full Text] [Related]
19. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
Jadhao SJ; Lee CW; Sylte M; Suarez DL
Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
